Therefore, PDPN expression may serve as a sensitive immunohistochemical marker for germinoma in CNS GCTs, aiding in diagnosis, monitoring treatment efficacy, and potential antibody-based therapy targeting. The gene discussed is PDPN; the disease is germinoma.